<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">14579153</PMID><DateCompleted><Year>2004</Year><Month>07</Month><Day>27</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0300-8584</ISSN><JournalIssue CitedMedium="Print"><Volume>193</Volume><Issue>2-3</Issue><PubDate><Year>2004</Year><Month>May</Month></PubDate></JournalIssue><Title>Medical microbiology and immunology</Title><ISOAbbreviation>Med Microbiol Immunol</ISOAbbreviation></Journal><ArticleTitle>Coxsackieviral replication and pathogenicity: lessons from gene modified animal models.</ArticleTitle><Pagination><StartPage>71</StartPage><EndPage>74</EndPage><MedlinePgn>71-4</MedlinePgn></Pagination><Abstract><AbstractText>Coxsackieviruses have been implicated in the pathogenesis of human myocarditis and some forms of dilated cardiomyopathy. A considerable portion of our knowledge about the pathophysiology of viral heart disease is derived from animal studies. In particular, investigations utilising gene-targeted mice provide valuable new insights into various aspects of viral pathogenicity and host factors involved in the control of viral replication. This review focuses on models in cell culture and transgenic animals mimicking coxsackieviral persistence, demonstrating that remarkably low persisting levels of replication-restricted coxsackieviral genomes are associated with an induction of a cytopathic effect in cardiac myocytes, leading to dilated cardiomyopathy in a transgenic mouse model. In this particular animal model, a phenotype is revealed which closely resembles the major hallmarks of human dilated cardiomyopathy. The impact of the innate immune system on coxsackieviral replication is demonstrated by studies in gene-targeted mice deficient of either type I or type II interferon signalling, which have indicated that type I but not type II interferons are essential for the control of early viral replication and survival of coxsackieviral infection.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wessely</LastName><ForeName>Rainer</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Deutsches Herzzentrum and 1. Medizinische Klinik, Klinikum rechts der Isar, Technische Universit&#xe4;t, Lazarettstrasse 36, 80636 Munich, Germany rwessely@dhm.mhn.de</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2003</Year><Month>10</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Med Microbiol Immunol</MedlineTA><NlmUniqueID>0314524</NlmUniqueID><ISSNLinking>0300-8584</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002311" MajorTopicYN="N">Cardiomyopathy, Dilated</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003384" MajorTopicYN="N">Coxsackievirus Infections</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="Y">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004770" MajorTopicYN="N">Enterovirus</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000472" MajorTopicYN="Y">pathogenicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="Y">Virus Replication</DescriptorName></MeshHeading></MeshHeadingList><NumberOfReferences>28</NumberOfReferences></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2003</Year><Month>3</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>10</Month><Day>28</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2004</Year><Month>7</Month><Day>28</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>10</Month><Day>28</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">14579153</ArticleId><ArticleId IdType="doi">10.1007/s00430-003-0203-0</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Am J Pathol. 1980 Nov;101(2):425-84</Citation><ArticleIdList><ArticleId IdType="pubmed">6254364</ArticleId></ArticleIdList></Reference><Reference><Citation>Rev Med Virol. 2001 Nov-Dec;11(6):355-68</Citation><ArticleIdList><ArticleId IdType="pubmed">11746998</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2000 May;74(9):4284-90</Citation><ArticleIdList><ArticleId IdType="pubmed">10756043</ArticleId></ArticleIdList></Reference><Reference><Citation>J Biol Chem. 1995 Sep 29;270(39):23173-8</Citation><ArticleIdList><ArticleId IdType="pubmed">7559464</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 1995 Nov;69(11):6720-8</Citation><ArticleIdList><ArticleId IdType="pubmed">7474082</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur Heart J. 1995 Dec;16 Suppl O:147-9</Citation><ArticleIdList><ArticleId IdType="pubmed">8682084</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 1992 Jan 1;89(1):314-8</Citation><ArticleIdList><ArticleId IdType="pubmed">1309611</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 1992 Nov;166(5):958-65</Citation><ArticleIdList><ArticleId IdType="pubmed">1328409</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 1999 Mar;73(3):1756-66</Citation><ArticleIdList><ArticleId IdType="pubmed">9971752</ArticleId></ArticleIdList></Reference><Reference><Citation>Circulation. 1998 Aug 4;98(5):450-7</Citation><ArticleIdList><ArticleId IdType="pubmed">9714096</ArticleId></ArticleIdList></Reference><Reference><Citation>Heart. 2001 Dec;86(6):687-92</Citation><ArticleIdList><ArticleId IdType="pubmed">11711469</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Invest. 1998 Oct 1;102(7):1444-53</Citation><ArticleIdList><ArticleId IdType="pubmed">9769337</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 1994 Jan;68(1):1-5</Citation><ArticleIdList><ArticleId IdType="pubmed">8254718</ArticleId></ArticleIdList></Reference><Reference><Citation>Lab Invest. 1998 Oct;78(10):1227-37</Citation><ArticleIdList><ArticleId IdType="pubmed">9800948</ArticleId></ArticleIdList></Reference><Reference><Citation>Circulation. 2001 Feb 6;103(5):756-61</Citation><ArticleIdList><ArticleId IdType="pubmed">11156890</ArticleId></ArticleIdList></Reference><Reference><Citation>Intervirology. 1993;35(1-4):140-51</Citation><ArticleIdList><ArticleId IdType="pubmed">8407241</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Invest. 1995 Sep;96(3):1311-8</Citation><ArticleIdList><ArticleId IdType="pubmed">7657806</ArticleId></ArticleIdList></Reference><Reference><Citation>Am Heart J. 1988 Jun;115(6):1229-32</Citation><ArticleIdList><ArticleId IdType="pubmed">2837073</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Cardiol. 1994 Oct;17 (10 ):563-5</Citation><ArticleIdList><ArticleId IdType="pubmed">8001305</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Immunol Immunopathol. 1993 Aug;68(2):159-69</Citation><ArticleIdList><ArticleId IdType="pubmed">7689428</ArticleId></ArticleIdList></Reference><Reference><Citation>Circulation. 1999 Feb 23;99(7):889-95</Citation><ArticleIdList><ArticleId IdType="pubmed">10027811</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 1994 Jun 24;264(5167):1918-21</Citation><ArticleIdList><ArticleId IdType="pubmed">8009221</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 1993 Mar 19;259(5102):1742-5</Citation><ArticleIdList><ArticleId IdType="pubmed">8456301</ArticleId></ArticleIdList></Reference><Reference><Citation>Circ Res. 1999 Sep 17;85(6):559-61</Citation><ArticleIdList><ArticleId IdType="pubmed">10488059</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 1987 Jan;84(1):21-5</Citation><ArticleIdList><ArticleId IdType="pubmed">3467351</ArticleId></ArticleIdList></Reference><Reference><Citation>J Mol Cell Cardiol. 1985 Feb;17(2):167-81</Citation><ArticleIdList><ArticleId IdType="pubmed">3889351</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Cardiol. 1997 Oct;20(10):857-63</Citation><ArticleIdList><ArticleId IdType="pubmed">9377822</ArticleId></ArticleIdList></Reference><Reference><Citation>Z Kardiol. 1998 Jun;87(6):443-52</Citation><ArticleIdList><ArticleId IdType="pubmed">9691414</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>